Board of Directors

Adrian currently functions as the company’s executive chair as well as the chairman of the board. Prior to these roles, he functioned as an investor board member since 2018. Adrian is also the Chief Executive Officer at The VOID, an immersive virtual reality entertainment provider, where he is responsible for overseeing the company’s growth. Since 1999, he has been building companies from the ground up and working to enable voice and data communications in countries around the world.

Adrian previously served as CEO of OneWeb, a London-based global communications company, and lusacell, a very successful mobile carrier in Mexico, which sold to AT&T in 2015. He also led the buildout and operations of the fiber backbones in both Colombia and Peru in cooperation with their respective governments and during his time as CFO at TV Azteca, he took the company public on the New York Stock Exchange (NYSE).

Follow Adrian at: @adriansteckel

Dr. Peter Noseworthy, MD is the Medical Director, Department of Business Development and Cardiologist in Cardiac Electrophysiology at Mayo Clinic. Previously, he was a Cardiac Electrophysiology Fellow at Massachusetts General Hospital and Research Fellow at Broad Institute of MIT and Harvard. He received his MBA from MIT.

Caleb has nearly 20 years of operating, startup, and financing experience in life science and healthcare companies. He plays an instrumental role in sourcing and structuring deals and works closely with portfolio companies to form strategic partnerships and to develop commercialization and marketing strategies. He currently (or formerly) represents Excel as a Board Director or Observer at Aventura, InfoBionic, Molecular Templates, ShapeUp, Saladax Biomedical, and MedVentive (sold to McKesson). Prior to joining Excel, Caleb was a Principal at Biotechonomy, where he financed and managed several entrepreneurial ventures, including Synthetic Genomics, where he was also the Director of Finance, BioTrove (sold to Life Technologies), Biocius (sold to Agilent Technologies), and Xcellerex (sold to GE).

Prior to becoming a venture capitalist, Caleb was an award winning sales and marketing executive at medical device and diagnostics companies. He received his M.B.A. from Babson College, magna cum laude, where he was a Babson Fellow in the Center for Technology Enterprise. He received a B.A. in Biology with a minor in Economics from Colby College.

Stuart was appointed CEO of InfoBionic.Ai in March 2017, underscoring the Company’s commitment to widespread market adoption of its transformative wireless remote patient monitoring platform for chronic disease management. With more than 20 years of experience in the medical device market, Stuart brings a great deal of expertise in achieving rapid commercial growth. Prior to joining InfoBionic.Ai, he was CEO at Monarch Medical Systems, LLC, a Charlotte-based, artificial intelligence clinical decision support software provider for insulin dosing calculations, where he oversaw the organizational restructuring of the company.

Prior to Monarch, Stuart served as the global chief marketing and sales officer for Capsule Tech, Inc., a medical device integration and clinical data management system for hospitals and healthcare institutions. During his tenure, he developed and executed a strategic business and product plan that ultimately led to the company’s acquisition by Qualcomm Life, Inc., a subsidiary of Qualcomm, Inc. Prior to Capsule Tech, Stuart worked in executive leadership at Philips Healthcare, overseeing global product management and marketing for their healthcare imaging and informatics group as well as emerging markets in the company’s cardiac monitoring division. Stuart also held executive positions at healthcare IT-focused companies including Agfa Healthcare, AMICAS, FUJIFILM USA and Eastman Kodak in addition to his previous clinical experience of managing acute care, non-invasive cardiology.

Gerardo Ibarra is CFO at InfoBionic.Ai. His experience includes 20 years in Grupo Salinas where he occupied various positions in telecom business units in Mexico, Colombia and Peru, actively participating in various high profile M&A and corporate finance telecom transactions. Mr. Ibarra was also involved in the oversight of certain investments made by Grupo Salinas in ventures in the telecom, VR, health care and the Fintech space. Mr. Ibarra holds a major in accounting from the Instituto Tecnológico Autónomo de México (Mexico City) and an MSc. in International Economics, Banking and Finance from the University of Cardif (U.K.).

Darren Carney is Director of Licensing at Mayo Clinic. Previously, he was a Senior Licensing Manager and Technology Licensing Manager at Mayo Clinic. He received a Ph.D. in Biological Chemistry from UT Southwestern Medical Center and a BS in Biology and Biochemistry from Trinity University.

Eric Klavetter is an Administrator of Cardiovascular Medicine at Mayo Clinic. Previously, he was an Administrator of Family Medicine and Acquisitions and Affiliations at Mayo Clinic. He received a BS degree in Chemistry from South Dakota State University.

Eric has more than 25 years of experience as a strategic executive, private equity investor, advisor, and board member working with public and private growth companies to drive business transformation, develop and implement strategic operating plans, and manage corporate finance and M&A transactions.

Eric joined Safeguard as its Chief Restructuring Officer in April 2020 and is responsible for developing and executing its strategy, managing day-to-day operations, and engaging with public shareholders. Eric serves as Safeguard’s board member at InfoBionic.Ai. and as a board observer at MediaMath, Inc.

Eric has extensive experience helping companies manage through different stages of growth and maturation. He has served as a board member and advisor to portfolio companies of several public and private technology companies representing funds including Ares, Athyrium, Blackstone/GSO, Carlyle, and KKR. Eric currently serves as an independent director on the board of publicly traded 8×8, Inc., where he is Chairman of the Compensation Committee, and privately owned SolAero Technologies, Inc, where he is Chairman of the Board.

Eric spent nearly ten years employed by Lehman Brothers as a Managing Director.